These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 27428782)

  • 1. Preclinical evaluation of near-infrared (NIR) fluorescently labeled cetuximab as a potential tool for fluorescence-guided surgery.
    Saccomano M; Dullin C; Alves F; Napp J
    Int J Cancer; 2016 Nov; 139(10):2277-89. PubMed ID: 27428782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
    Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
    Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
    Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
    Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery.
    Gutowski M; Framery B; Boonstra MC; Garambois V; Quenet F; Dumas K; Scherninski F; Cailler F; Vahrmeijer AL; Pèlegrin A
    Surg Oncol; 2017 Jun; 26(2):153-162. PubMed ID: 28577721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sensitivity detection of breast tumors in vivo by use of a pH-sensitive near-infrared fluorescence probe.
    Mathejczyk JE; Pauli J; Dullin C; Resch-Genger U; Alves F; Napp J
    J Biomed Opt; 2012 Jul; 17(7):076028. PubMed ID: 22894511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging.
    Tummers WS; Miller SE; Teraphongphom NT; Gomez A; Steinberg I; Huland DM; Hong S; Kothapalli SR; Hasan A; Ertsey R; Bonsing BA; Vahrmeijer AL; Swijnenburg RJ; Longacre TA; Fisher GA; Gambhir SS; Poultsides GA; Rosenthal EL
    Ann Surg Oncol; 2018 Jul; 25(7):1880-1888. PubMed ID: 29667116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody.
    van Driel PB; van der Vorst JR; Verbeek FP; Oliveira S; Snoeks TJ; Keereweer S; Chan B; Boonstra MC; Frangioni JV; van Bergen en Henegouwen PM; Vahrmeijer AL; Lowik CW
    Int J Cancer; 2014 Jun; 134(11):2663-73. PubMed ID: 24222574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice.
    Hiroshima Y; Maawy A; Sato S; Murakami T; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Surg Res; 2014 Apr; 187(2):510-7. PubMed ID: 24373959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
    Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
    Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent.
    Hoogstins CES; Boogerd LSF; Sibinga Mulder BG; Mieog JSD; Swijnenburg RJ; van de Velde CJH; Farina Sarasqueta A; Bonsing BA; Framery B; Pèlegrin A; Gutowski M; Cailler F; Burggraaf J; Vahrmeijer AL
    Ann Surg Oncol; 2018 Oct; 25(11):3350-3357. PubMed ID: 30051369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma.
    Li M; Wei W; Barnhart TE; Jiang D; Cao T; Fan K; Engle JW; Liu J; Chen W; Cai W
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2737-2748. PubMed ID: 33537836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging.
    Wang K; Wang K; Li W; Huang T; Li R; Wang D; Shen B; Chen X
    Acta Radiol; 2009 Dec; 50(10):1095-103. PubMed ID: 19922304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expressing Pancreatic Cancer.
    Olson MT; Aguilar EN; Brooks CL; Isder CC; Muilenburg KM; Talmon GA; Ly QP; Carlson MA; Hollingsworth MA; Mohs AM
    Mol Pharm; 2022 Oct; 19(10):3586-3599. PubMed ID: 35640060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
    Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.
    Boonstra MC; Tolner B; Schaafsma BE; Boogerd LS; Prevoo HA; Bhavsar G; Kuppen PJ; Sier CF; Bonsing BA; Frangioni JV; van de Velde CJ; Chester KA; Vahrmeijer AL
    Int J Cancer; 2015 Oct; 137(8):1910-20. PubMed ID: 25895046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
    Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
    J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using a Fluorescently Labelled Anti-CEA Nanobody Probe: A Preclinical Study.
    van Manen L; de Muynck LDAN; Baart VM; Bhairosingh S; Debie P; Vahrmeijer AL; Hernot S; Mieog JSD
    Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
    Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
    Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIRDye 812: A molecular platform tailored for multimodal bioimaging applications of targeted fluorescence- and photoacoustic-guided surgery.
    Hettie KS; Chin FT
    J Photochem Photobiol B; 2023 May; 242():112683. PubMed ID: 36934549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence Lifetime-Based Tumor Contrast Enhancement Using an EGFR Antibody-Labeled Near-Infrared Fluorophore.
    Pal R; Kang H; Choi HS; Kumar ATN
    Clin Cancer Res; 2019 Nov; 25(22):6653-6661. PubMed ID: 31481509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.